| Recurrence | No recurrence | P-value | |
---|---|---|---|---|
N | 28 | 38 | Â | |
Sex (M/F) | 16/12 | 24/14 | 0.80 | |
Age at presentation (yr) | 19 (4–57) | 28 (1–61) | 0.45 | |
Age at diagnosis (yr) | 23 (5–57) | 34 (2–61) | 0.13 | |
Body mass index at diagnosis in patients >16 yr (n=48) | 24.6 ± 3.6 (n=12) | 25.0 ± 3.5 (n=26) | 0.76 | |
eGFR at diagnosis (ml/min/1.73 m2) | 104 ± 50 (n=21) | 53 ± 22 (n=22) | <0.01 | |
Serum albumin at diagnosis (g/l) | 20 ± 9 (n=20) | 33 ± 10 (n=24) | <0.01 | |
24-hour protein excretion (g) | 11.7 ± 8.8 (n=15) | 4.6 ± 2.7 (n=14) | <0.01 | |
Interval onset to diagnosis (yr) | 0.3 (0–6.9) | 1.0 (0–22) | <0.01 | |
Interval diagnosis to ESRD (yr) | 4.9 (0.1-16.8) | 3.7 (0.2-32.4) | 0.96 | |
Interval ESRD to Tx (yr) | 1.2 (0–4.7) | 1.5 (0–9.3) | 0.34 | |
Age at transplantation (yr) | 32 (10–62) | 44 (5–68) | 0.06 | |
Donor age (yr) | 36.5 (5–64) | 38 (0–68) | 0.60 | |
Number of HLA mismatches | 2.0 ± 1.2 | 2.1 ± 1.2 | 0.81 | |
Donor source (n) | Deceased | 24 | 27 | 0.35 |
Living unrelated | 1 | 4 | ||
Living related | 3 | 7 | ||
Baseline immunosuppressive regimen (n) | P, CsA | 18 | 23 | 0.64 |
P, Aza | 5 | 4 | ||
P, CsA, MMF | 2 | 2 | ||
P, tacro, MMF | 3 | 8 | ||
Dacl, tacro, MMF | 0 | 1 |